These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 17210946)

  • 1. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
    Schrag D; Hanger M
    J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
    Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
    J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists.
    Newell S; Sanson-Fisher RW; Girgis A; Bonaventura A
    Cancer; 1998 Oct; 83(8):1640-51. PubMed ID: 9781960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communicating with patients about chemotherapy costs.
    de Lemos ML
    J Clin Oncol; 2007 May; 25(15):2142; author reply 2142. PubMed ID: 17513825
    [No Abstract]   [Full Text] [Related]  

  • 6. Australian oncologists' self-reported knowledge and attitudes about non-traditional therapies used by cancer patients.
    Newell S; Sanson-Fisher RW
    Med J Aust; 2000 Feb; 172(3):110-3. PubMed ID: 10735020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion of physical activity among oncologists in the United States.
    Karvinen KH; DuBose KD; Carney B; Allison RR
    J Support Oncol; 2010; 8(1):35-41. PubMed ID: 20235422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
    Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
    J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer therapy costs influence treatment: a national survey of oncologists.
    Neumann PJ; Palmer JA; Nadler E; Fang C; Ubel P
    Health Aff (Millwood); 2010; 29(1):196-202. PubMed ID: 20048377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologists' and physiatrists' attitudes regarding rehabilitation for patients with advanced cancer.
    Spill GR; Hlubocky FJ; Daugherty CK
    PM R; 2012 Feb; 4(2):96-108. PubMed ID: 22373458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do oncologists believe new cancer drugs offer good value?
    Nadler E; Eckert B; Neumann PJ
    Oncologist; 2006 Feb; 11(2):90-5. PubMed ID: 16476830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported practices and attitudes of US oncologists regarding off-protocol therapy.
    Peppercorn J; Burstein H; Miller FG; Winer E; Joffe S
    J Clin Oncol; 2008 Dec; 26(36):5994-6000. PubMed ID: 19029413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost issues in new disease-modifying treatments for advanced cancer: in-depth interviews with physicians.
    de Kort SJ; Kenny N; van Dijk P; Gevers S; Richel DJ; Willems DL
    Eur J Cancer; 2007 Sep; 43(13):1983-9. PubMed ID: 17616456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary survey of oncologists' perceptions of quality of life information.
    Bezjak A; Ng P; Taylor K; MacDonald K; Depetrillo AD
    Psychooncology; 1997 Jun; 6(2):107-13. PubMed ID: 9205968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan.
    Hyodo I; Eguchi K; Nishina T; Endo H; Tanimizu M; Mikami I; Takashima S; Imanishi J
    Cancer; 2003 Jun; 97(11):2861-8. PubMed ID: 12767101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?
    Grunfeld EA; Ramirez AJ; Maher EJ; Peach D; Young T; Albery IP; Richards MA
    Br J Cancer; 2001 May; 84(9):1172-8. PubMed ID: 11336466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving roles of oncology pharmacists in Singapore: a survey on prescribing patterns of antiemetics for chemotherapy induced nausea and vomiting (CINV) at a cancer centre.
    Chan A; Shih V; Chew L
    J Oncol Pharm Pract; 2008 Mar; 14(1):23-9. PubMed ID: 18337437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical oncologists' attitudes and practice in cancer pain management: a national survey.
    Breuer B; Fleishman SB; Cruciani RA; Portenoy RK
    J Clin Oncol; 2011 Dec; 29(36):4769-75. PubMed ID: 22084372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center.
    Fadul N; Elsayem A; Palmer JL; Del Fabbro E; Swint K; Li Z; Poulter V; Bruera E
    Cancer; 2009 May; 115(9):2013-21. PubMed ID: 19235253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer: report on a survery by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care.
    Cherny NI; Catane R;
    Cancer; 2003 Dec; 98(11):2502-10. PubMed ID: 14635087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.